INTRODUCTION

Prime Therapeutics, LLC is the current PBM and has served in this capacity since 2016. The Plan currently utilizes Prime’s NetResults formulary which is a “closed” formulary. The Plan processed over $283 million in 2019 prescription drug charges on approximately 3.3 million claims in 2019. ................
................